The New York-based contract research organization (CRO) will use OmniComm’s TrialMaster version 5 for the development and management of its clinical trials as part of the five-year agreement.
A spokesperson for Symbio told us that the company has been working with OmniComm for several years. Through the companies’ existing partnership, Symbio has been responsible for electronic case report form (eCRF) design, edit check specification, data cleaning, training and locking procedures.
“Basically, OmniComm has done the technology portion while Symbio has been doing the clinical data management portion. With this agreement now in place, Symbio is able to build, deploy, and update the clinical study database directly in the TrialMaster system without having to go through OmniComm to do so,” the spokesperson explained.
With this agreement in place, Symbio can get to a go-live state and implement post-production changes quicker than it could previously since it does not have a third party to schedule with, enabling the company to be more cost efficient, the spokesperson said
“The investigational research sites appreciate a consistent theme and workflow from study to study, as do our sponsors. This greatly reduces training, errors, and frustration for everyone,” they added.
In 2018, Symbio launched its European operations to support clients with global trial and stated that OmniComm’s presence in Europe was a major factor in the selection of using TrialMaster.